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Abstract
Background Enterocutaneous ﬁstulas (ECF) pose a major
challenge to every gastrointestinal (GI) surgeon. Based on
earlier studies, a standardized treatment guideline was
implemented. The focus of the present study was to assess
that guideline and determine prognostic factors for out-
come of patients with ECF, and to deﬁne a more detailed
therapeutic approach including the convalescence time
before restorative surgery.
Methods All patients with ECF treated between 1990 and
2005 were included. Management consisted of controlling
Sepsis, Optimization of nutritional state, Wound care,
assessment of ﬁstula Anatomy, Timing of surgery, and
Surgical strategy (the SOWATS guideline). Prognostic
factors were assessed by way of multiple logistic regression
analysis.
Results A total of 135 patients were treated at our unit.
Overall closure was achieved in 118 patients (87.4%).
Restorative operations for ﬁstula closure were performed
after a median of 53 days (range: 4–270 days). Restorative
operations were successful in 97/107 patients (90.7%).
Thirteen patients (9.6%) died. An abdominal wall defect
was the most predominant negative prognostic factor for
spontaneous closure (odds ratio [OR] = 0.195, conﬁdence
interval [CI] 0.052–0.726, p = 0.015). A strong relation was
found between preoperative albumin level and surgical
closure (p\0.001) and mortality (p\0.001).
Conclusions Application of the SOWATS guideline
allowed a favorable outcome after a short convalescence
period. Abdominal wall defects and preoperative hypoal-
buminemia are important prognostic variables.
The treatment of patients with enterocutaneous ﬁstulas
(ECF) is complex and a challenge to every gastrointestinal
(GI) surgeon. Since the ﬁrst major report in 1960 [1],
reporting a mortality rate of 44%, much energy has been
invested in optimizing the treatment of patients with ECF.
In the second half of the last century, mortality decreased
to 5%–25% [2–5] because of improved surgical, metabolic,
and medical care. At present, the treatment of patients with
an abdominal wall defect in which a ﬁstula develops in the
exposed intestine is probably the biggest challenge [6]. The
few retrospective studies available in the literature con-
cerning these patients are either incomplete or only
describe small series of patients [7–12] (Tables 1, 2, 3).
Overall, the incidence of ECF is low. Consequently,
randomized studies are lacking and management principles
are based on expert opinion. There is no evidence-based
grade A recommendation on how these patients should be
treated, but a few paradigms exist: spontaneous closure is
less common in ﬁstulas caused by malignancy or Crohn’s
disease [13, 14] but is predominantly seen in colonic ECF,
in low-output ﬁstulas [14–17], and in patients with a closed
abdomen [7, 18]. There is consensus that treatment of
sepsis and restoring nutritional state are priorities. More-
over, it is generally recommended that patients not undergo
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DOI 10.1007/s00268-007-9371-1restorative surgery within 3–6 months after ECF develop-
ment [17, 19, 20].
In our unit, treatment of patients with ECF is stan-
dardized and based on the outcome of a large retrospective
study [2] and a study of patients treated in our unit
according to a standardized guideline [21]. Since this last
study, high-resolution computerized tomography (CT) has
become available, allowing precise drainage procedures of
abscesses by intervention radiology or local surgical
drainage [22, 23] instead of complete re-laparotomy. In
addition, materials have become available, such as
absorbable vicryl mesh, for temporary abdominal wall
closure. Moreover, we have changed to a more defensive
surgical technique. We have titrated the timing of restor-
ative surgery to individual patient conditions, as opposed to
a pre-planned time interval of 3–6 months between ﬁstula
occurrence and restorative surgery. Since 1990, all patients
with ECF admitted to our hospital have been treated
according to this renewed guideline.
The goal of the present study was to audit the results of
this approach in patients with complex ECF and to identify
the time of convalescence prior to restorative surgery. Our
secondary aim was to identify prognostic factors for ﬁstula
closure and mortality in these patients. More speciﬁcally,
we wanted to test if spontaneous closure was related to the
cause, output, and location of the ECF and the presence of
an abdominal wall defect.
Patients and methods
Patients
In this retrospective analysis, a database was created con-
sisting of 135 patients with ECF consecutively treated at
our unit between 1990 and 2005. Since 1990, all patients
have been treated according to the SOWATS guideline (see
Methods, below). Patients with gastroduodenal, pancreatic,
Table 1 Overview of the
literature. Overall results
a Gastrointestinal ﬁstulas
b Entercoutaneous ﬁstulas
c Small bowel ﬁstulas
Author Number of
patients
Surgical
closure, %
Spontaneous
closure, %
Overall
mortality, %
Sitges-Serra et al. [7]
a 75 13.3 65.3 21.3
Conter et al. [8]
b 51 80.4 9.8 7.8
Levy et al. [9]
c 335 37.3 29 33.7
Schein and Decker [10]
a 117 NA NA 37
Chamberlain et al. [11]
c 25 24 32 40
Hollington et al. [12]
a 277 43.7 25.6 15.2
Present study
b 135 71.9 15.6 9.7
Table 2 Overview of literature.
Results of ﬁstulas within a
closed abdominal wall
a Gastrointestinal ﬁstulas
b Entercoutaneous ﬁstulas
c Small bowel ﬁstulas
d Success rate is 72%
Author Number of
patients
Surgical
closure, %
Spontaneous
closure, %
Overall
mortality, %
Sitges-Serra et al [7]
a 65 10.8 73.8 15.4
Conter et al. [8]
b 36 NA 13.9 NA
Levy et al. [9]
c 170 NA NA 23
Schein and Decker [10]
a 72 NA NA 22.2
Chamberlain et al. [11]
c 22 27.3 36.4 31.8
Hollington et al. [12]
a 245 NA NA 14.6
d
Present study
b 82 68.3 22 6.1
Table 3 Overview of literature.
Results of ﬁstulas with an
abdominal wall defect
a Gastrointestinal ﬁstulas
b Entercoutaneous ﬁstulas
c Small bowel ﬁstulas
d Success rate is 47%
NA not available
Author Number of
patients
Surgical
closure, %
Spontaneous
closure, %
Overall
mortality, %
Sitges-Serra et al. [7]
a 10 30 10 60
Conter et al. [8]
b 15 NA 0 NA
Levy et al. [9]
c 165 NA NA 44
Schein and Decker [10]
a 45 NA NA 60
Chamberlain et al. [11]
c 3 0 0 100
Hollington et al. [12]
a 32 NA NA 18.8
d
Present study
b 53 77.3 5.7 15.1
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123biliary, and perianal ﬁstulas were excluded. Patients who
displayed intestinal anastomotic leakage soon after the
primary surgical procedure and immediately underwent re-
laparotomy were not deﬁned as having an ECF. However,
when no re-laparotomy was performed and patients
developed an ECF, they were treated according to the
guideline. Information was gathered from the nutrition
team database and from patient ﬁles.
An ECF was considered to be closed when there was no
communication between the intestine and the abdominal
wall, and no signs of inﬂammation. Subsequently, recur-
rence was deﬁned as a renewed connection between the
intestine and skin after the ﬁstula either had been surgically
removed or had spontaneously closed. Abdominal wall
defect is deﬁned as any defect of all layers of the abdom-
inal wall leaving the abdominal contents exposed.
Methods
The SOWATS treatment guideline consists of the follow-
ing components: Sepsis, Optimization of nutritional state,
Wound care, Anatomy (of the ﬁstula), Timing of surgery,
and Surgical strategy. It is roughly similar to the treatment
approach advocated in earlier reports [2, 12, 17, 19, 21, 24–
26]. Each of the components of the protocol is described
below:
• Sepsis. Control of sepsis has the highest priority. The
suspicion of a septic focus is based on one or more
clinical signs: fever, failure to respond to nutrition, and
jaundice, accompanied with increased infection param-
eters, decreased plasma albumin levels, positive ﬂuid
balance, development of edema, and organ failure.
These signs are sometimes different and blunted when
patients are clinically depleted, which is often the case
in ECF patients. When clinical signs indicate the
presence of a septic focus, enteral and intravenous
contrast-enhanced CT is used to identify and outline
abscesses and to guide percutaneous drainage or local
surgical drainage procedures. Complete re-laparotomy
is avoided between 1 and 6 weeks after the initial
surgery or the occurrence of the ECF. At this stage,
dissection is difﬁcult and likely to cause damage to the
abdominal contents [27].
• Optimization of nutritional state. Nutritional manage-
ment is always preceded by rehydration and electrolyte
correction. Within 24–48 h after the appearance of (a)
small bowel ﬁstula(s) parenteral nutrition is initiated
and includes the administration of trace elements and
vitamins. Enteral nutrition is considered in cases of
small bowel ﬁstulas not expected to close spontane-
ously, in large bowel ﬁstulas, and when ﬁstula output
does not interfere with wound care. Patients are always
allowed to ingest clear ﬂuids up to 500 ml/day.
• Wound care: Specialist wound care is applied to
prevent maceration and excoriation of the skin by
intestinal ﬂuid leakage from the ﬁstula, precluding
proper healing after the restorative operation and
abdominal wall reconstruction in a later stage opera-
tion. Fluids are collected in a wound manager and
drained through sump-suction, which also allows
output measurement.
• Anatomy. The anatomy of the ﬁstula is deﬁned prior to
planned surgery. Contrast studies are performed in
which water-soluble contrast material is administered
through the ﬁstula, orally, and rectally. The complete
bowel tract is visualized so that the surgeon can be
informed about the ﬁstula anatomy, the length of the
proximal bowel, and the quality of the remaining bowel
(obstruction/stenosis).
• Timing of surgery. Patients are eligible for surgery
when septic foci are adequately treated and subjective
criteria for a good clinical and nutritional condition are
met. These criteria include the patient’s becoming
mobile, feeling well, taking an interest in his/her
surroundings, and becoming impatient to proceed with
the restorative surgery. The absence of signs of sepsis
is deﬁned by increasing albumin and hemoglobin and
decreasing leukocyte and thrombocyte counts,
C-reactive protein and erythrocyte sedimentation rate
levels. The minimal period between the development
of the ﬁstula and the restorative surgical approach is
6 weeks.
• Surgical strategy. There are some distinct surgical
principles to be reckoned with: Complete dissection of
the bowel tract is necessary to ensure unhindered
passage and to allow mobilization of the abdominal
wall and thereby facilitate closure at the end of the
operation. The number of anastomoses is limited to a
minimum, and each one must be covered with healthy
tissue and positioned away from other sutures lines.
Use of a non-absorbable mesh is avoided to reduce the
possibility of infection and recurrence of ﬁstulas. In
some cases a proximal double-barrelled small bowel
enterostomy is constructed to protect more distal
anastomoses that are at risk of leakage. These enteros-
tomies are placed in such a manner that later closure is
possible through local small incisions.
Statistical analysis
Univariate analysis was performed using Pearson’s chi-
square test and Fisher’s exact test where appropriate.
Independent variables affecting ECF closure included age
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123(younger or older than 60 years), sex, patient origin (Uni-
versity Hospital Maastricht (azM) or other), primary
disease (inﬂammatory bowel disease, malignancy or a
miscellaneous group consisting of appendicitis, diverticu-
litis, ileus, several nonmalignant processes, and vascular
diseases, among others), cause (postsurgical or spontane-
ous), anatomy (small or large bowel), output (\500 or C
500 ml/day), abdominal wall status (open or closed), sepsis
(yes or no), only total parenteral nutrition (TPN: yes or no),
recurrence of ﬁstula (yes or no), and albumin level before
restorative surgery (\25 or C 25 g/l). Outcome variables
included spontaneous closure, surgical closure, and death.
The patient was the unit of analysis, and all independent
variables with a two-tailed p\0.10 were included into a
multiple logistic regression model. The ﬁnal model was
reduced by the backward elimination method based on the
likelihood ratio test. Two-tailed p\0.05 were considered
signiﬁcant. Statistical analyses were performed with SPSS
software (version 13; SPSS Inc., Chicago, IL, USA).
Results
Patient characteristics
Data from 135 patients experiencing 163 episodes of ECF
were analyzed (Table 4). Mean age was 57 years (range:
16–87 years). Postoperative ﬁstulas after initial surgery
appeared after a median of 21 days (range: 1–494 days).
The median length of hospital stay was 56 days (range:
6–317 days). However, because several patients received
treatment including TPN at home, the median period of
treatment was 70 days (range: 6–497 days). Intensive care
treatment and artiﬁcial ventilation were necessary for 33
patients during 50 ICU admissions, lasting a median of
8.5 days (range: 1–171 days).
Treatment of infectious complications and nutritional
management
Most patients referred to our hospital had suffered a septic
episode in the referring hospital. A total of 73 patients
experienced one or more septic episodes in our department.
In this latter group 15 patients had radiological signs of
small or very superﬁcial collections and were treated with
antibiotics only. Computerized tomography-guided drain-
age of abscesses was necessary in 28 patients, none of
whom required further intervention. A drainage procedure
was attempted in three patients but was technically
impossible. Five patients underwent drainage through local
incisions, and one of those patients eventually required a
re-laparotomy. Re-laparotomy was performed as a ﬁrst
choice in six patients because of fecal peritonitis, abdom-
inal compartment syndrome, and the presence of multiple
abscesses. Additionally, 10 patients had a CT without proof
of an abdominal focus for sepsis. Most often, the primary
source of infection in these patients was the central venous
line and to a lesser extent, the urinary tract and the lungs.
Six patients with sepsis did not receive a CT but were
immediately diagnosed with a central venous line infec-
tion. In total, central venous line infections were seen in 25
patients. One patient died from catheter-related sepsis.
Overall, sepsis could not be controlled in 10 patients, all of
whom later died.
Total parenteral nutrition alone was administered to 82
patients for a median of 44 days (range: 3–219 days).
Twenty patients received enteral nutrition in combination
with parenteral feeding, and 33 patients received total
enteral nutrition without compromising wound care.
Patient outcome
Fistula closure was accomplished in 118 patients, giving an
overall success rate of 87.4%. Spontaneous closure
occurred in 21 patients (15.6%) and surgical closure was
achieved in 97 patients (71.9%) (Table 5). The median
time between ﬁstula development and spontaneous closure
was 18 days (range: 7–49 days). Surgical intervention was
performed after a median period of 53 days (range: 4–
270 days) from occurrence of the ﬁstula. The overall suc-
cess of surgical treatment was 90.7%, and the overall
mortality rate was 9.6% (13 patients). Of the 13 patients
who died, 3 died of non-ﬁstula- related causes: cancer (2)
and myocardial infarction (1). Sepsis was the cause of
death in the remaining 10 patients, resulting in a ﬁstula-
related mortality of 7.4%. Four patients died before
undergoing restorative surgery, and four others did not
ﬁnish treatment at our department but were transferred to
other hospitals or institutions (Fig. 1). In only one of these
patients was a decision made to refrain from restorative
surgery because of progressive malignancy.
Abdominal wall
An abdominal wall defect was present in 53 patients
(Tables 4 and 5). Causes for the abdominal wall defects
included (1) spontaneous dehiscence after surgery, result-
ing from bowel distension and adynamic ileus; (2)
infectious complications, or (3) intentional opening of the
abdominal wall in case of increased intra-abdominal pres-
sure leading to cardiovascular instability. Closure of the
ﬁstula was accomplished in 44 patients (83.0%). Sponta-
neous closure was seen in only 3 of these patients (5.7%),
448 World J Surg (2008) 32:445–453
123closure through restorative surgery was achieved in 41
patients (77.3%). Because a total of 49 patients underwent
restorative surgery, the surgical success rate within this
group was 83.7%. Eight patients (15.1%) died of sepsis, all
following restorative surgery. One patient was transferred
to another hospital with an open ﬁstula. All patients who
were treated successfully left the hospital with a closed
abdomen, and at least a quarter of these patients later
required correction of a newly developed abdominal wall
hernia.
Spontaneous closure
Several variables were signiﬁcantly related to spontaneous
closure, surgical closure, and mortality (Table 6). Sponta-
neous closure predominantly occurred in patients with an
intact abdominal wall (p = 0.014), and in patients who
received TPN (p = 0.014). Multiple logistic regression
analysis showed that abdominal wall status and TPN
administration were independent predictors for spontane-
ous closure. The odds ratios for open versus closed
abdominal wall and for TPN administration versus no TPN
were 0.195 (CI 0.052–0.726; p = 0.015) and 5.466 (CI
1.464–20.410; p = 0.012), respectively. Patient origin was
retained in this model because of near signiﬁcance (OR =
3.310 CI 0.994–11.109; p = 0.051).
Surgical closure and mortality
Surgical closure was negatively associated with male sex
(p = 0.043), high output (p = 0.030), abdominal wall defect
(p = 0.041), presence of sepsis (p = 0.017), ﬁstula recur-
rence (p = 0.012), and a preoperative albumin level below
25 g/l (p\ 0.001). Mortality was higher in patients older
than 60 years (p = 0.002), of male sex (p = 0.040), with
high-output ﬁstulas (p = 0.031), sepsis (p = 0.006), and a
preoperative albumin level below 25 g/l (p \ 0.001)
(Table 6).
Table 4 Patient characteristics of the total population and of patients
with an open abdominal wall
Total population Open abdomen
Variable N % N %
Patients 135 100 53 100
Number of ﬁstulas 163 NA 60 NA
Age (years)
\60 67 49.6 22 41.5
C 60 68 50.4 31 58.5
Sex
Male 65 48.1 31 58.5
Female 70 51.9 22 41.5
Patient origin
azM surgical department 82 60.7 30 56.6
Other 53 39.3 23 43.4
Primary disease
Miscellaneous 81 60 37 69.8
IBD 24 17.8 5 9.4
Malignancy 30 22.2 11 20.8
Cause of ﬁstula
Surgical 119 88.1 51 96.2
Spontaneous 16 11.9 2 3.8
Anatomy of ﬁstula
Small bowel 104 77.0 47 88.7
Large bowel 26 19.3 5 11.3
Output (ml/day)
\500 56 41.5 15 28.3
C 500 61 45.2 31 58.5
Abdominal wall
Open 53 39.3 NA NA
Closed 82 60.7 NA NA
Sepsis
Yes 73 54.1 31 58.5
No 62 45.9 22 41.5
Only TPN
Yes 82 60.7 33 62.3
No 53 39.3 20 37.7
Recurrence
Yes 18 13.3 9 17.0
No 117 86.7 44 83.0
Preoperative albumin (g/l)
Table 4 continued
Total population Open abdomen
\25 25 24.3
a 14 28.6
b
C 25 62 60.2
a 24 49.0
b
a Percentage of total number initial surgical restorative procedures
(103)
b Percentage of total number initial surgical restorative procedures
(49)
azM University Hospital Maastrict; IBD inﬂammatory bowel disease;
TPN total parenteral nutrition
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123A strong relation was observed between preoperative
albumin levels and mortality (Table 6, Fig. 2), making
multiple logistic regression analysis impossible. Likewise,
success of surgery is strongly dependent on the preopera-
tive albumin level. All 62 patients with a preoperative
albumin level above 25 g/l survived with a healed ﬁstula.
Eight of 25 patients with a preoperative albumin level
below 25 g/l died (32%). The preoperative albumin level
was unknown in 20 patients, 1 of whom died. A subgroup
analysis of all 25 patients with an albumin level below
25 g/l showed that abdominal wall defect was the only
variable signiﬁcantly associated with mortality (p = 0.030).
Six of 12 patients (50%) with an abdominal wall defect
died, compared to 2 out of 13 (15%) patients with a closed
abdominal wall.
Discussion
The present study shows that adherence to a treatment
guideline for patients with ECF results in good general
outcome despite a relatively short period of convalescence.
The restorative operation was performed after a median
interval of 53 days, without compromising outcome, as
shown by a high success rate and low mortality. Timing of
surgery was titrated on the basis of day-to-day patient
characteristics instead of observing a ﬁxed time period
(3–6 months) between ﬁstula occurrence and restorative
surgery [17, 19, 20].
Spontaneous closure of ECF did not occur after
7 weeks. In our series, spontaneous closure was limited to
patients in whom ﬁstulas developed after primary surgery
in our own hospital. This patient bias is not surprising,
because ECF that tend to close spontaneously are unlikely
to be referred. A bias also occurs when considering the
effect of TPN. Because patients are given TPN and nil by
mouth when the ECF is already expected to close sponta-
neously, the multiple logistic regression analysis will be
inﬂuenced. Therefore we cannot conclude that bowel rest
facilitated by TPN promotes spontaneous closure. In
proximal high-output ﬁstulas, TPN is required to allow
administration of full nutritional requirements and to sim-
plify wound care by decreasing ﬁstula output [13, 28].
Interestingly, other variables used clinically in earlier
reports to judge the likelihood of spontaneous closure [14–
17] were not convincingly conﬁrmed in our study. Spon-
taneous closure of ECF was not inﬂuenced by anatomy
Table 5 Outcome of treatment in the total population and speciﬁed for abdominal wall status
Total population (n = 135) Open abdomen (n = 53) Closed abdomen (n = 82)
Number % Number % Number %
Closure 118 87.4 44 83.0 74 90.2
Spontaneous 21 15.6 3 5.7 18 22.0
Surgical 97 71.9 41 77.4 56 68.3
Success of surgery 97/107 90.7 41/49 83.7 56/58 96.6
Mortality 13 9.7 8 15.1 5 6.1
Persisting ﬁstula 4 3.0 1 1.9 3 3.7
135 Patients
23 Spontaneous Cure
3 Spontaneous Cure
4 Lost to Follow Up 
4 Deaths
104 Restorative Operations 
13 Restorative Operations 
5 Restorative Operations 
4 Restorative Operations 
5 Deaths
18 Recurrences
2 Deaths
5 Recurrences
4 Recurrences
1 Recurrences
1 Death
Fistula
Episode I
Fistula
Episode IV
Fistula
Episode III
Fistula
Episode V
Fistula
Episode II
1 Death
3 Recurrences
2 Recurrences
Fig. 1 Flow chart of patient outcome
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123(e.g., large or small bowel), by output, or by cause of the
ECF. However, an ECF within an abdominal wall defect
and not adjacent to viable skin is unlikely to close
spontaneously.
This study shows that hypoalbuminemic patients fail to
recover well after restorative surgery. Albumin levels
therefore provide, in addition to clinical signs, a good
measure to assess a patient’s health status [29–31], and
surgical intervention will ideally be performed when levels
are normal. Like other acute phase proteins [32], albumin
as an indicator of inﬂammatory activity is a potent indi-
cator of surgical risk [31]. It is well known that
Table 6 Univariate analysis of outcome
Spontaneous closure Surgical closure Mortality
Variable Ratio p Value Ratio p Value Ratio p Value
Age (years) 0.486 0.093 0.002
\60 12/67 51/53 1/67
C 60 9/68 46/54 12/68
Sex 1.000 0.043
* 0.040
Male 10/65 42/50 10/65
Female 11/70 55/57 3/70
Patient origin 0.051 0.746
a 0.766
azM surgical department 17/82 55/60 7/82
Other 4/53 42/47 6/53
Primary disease 0.675
a 0.722
a 0.294
a
Miscellaneous 11/81 60/65 7/81
IBD 4/24 19/21 1/24
Malignancy 6/30 18/21 5/30
Cause of ﬁstula 1.000
a 0.353
a 0.364
a
Surgical 19/119 83/93 13/119
Spontaneous 2/16 14/14 0/16
Anatomy of ﬁstula 0.763
a 1.000
a 1.000
*
Small bowel 17/104 75/83 10/104
Large bowel 3/26 20/22 2/26
Output 0.811 0.030
a 0.031
(ml/day)
\500 9/56 43/44 2/56
C 500 11/61 38/46 10/61
Abdominal wall 0.014 0.041
a 0.133
Open 3/53 41/49 8/53
Closed 18/82 56/58 5/82
Sepsis 1.000 0.017
a 0.006
Yes 11/73 47/56 12/73
No 10/62 50/51 1/62
Only TPN 0.014 1.000
a 1.000
Yes 18/82 53/59 8/82
No 3/53 44/48 5/53
Recurrence 0.306
a 0.012
a 0.073
a
Yes 1/18 13/18 4/18
No 20/117 84/89 9/117
Preoperative NA 0.000
a 0.000
a
Albumin (g/l)
\25 NA 17/25 8/25
C 25 NA 61/62 0/62
a Fisher’s exact test
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123inﬂammatory activity diminishes the ability of the patient
to respond well to a second hit [19]. In this study, 25
patients with an albumin level below 25 g/l underwent
operation. These patients represented a seriously ill group
that continued to show signs of inﬂammation despite all
endeavors to treat infection and in which postponement of
surgery was thought to lead to further deterioration.
The relatively low overall mortality rate of 10% in the
present study compares favorably with rates reported in the
literature (Tables 1–3). This is especially encouraging
because the current population consisted of a greater pro-
portion of patients with an abdominal wall defect, which
increased from around 20% (reference data not reported in
our publications) to 39% in the present series, and had
more co-morbidity compared to our previous studies [2,
27]. This improvement may be caused by more effective
and more rapid tackling of sepsis or as a result of improved
intensive care monitoring and treatment of septic foci by
CT-guided drainage or via small surgical incisions.
Mortality is related to sepsis, age, sex, and ﬁstula output.
Multi-organ failure caused by sepsis is still the main cause
of death in spite of advanced medical treatment. Although
treatment of complications should be optimized, it is also
important to prevent complications by improving the con-
dition of the patient before operation, but also to adapt the
extent of the surgical trauma to the patient’s ability to
adequately respond to that trauma. The increased risk of
postoperative sepsis in the elderly has also been demon-
strated by other investigators [33].
The main lesson to be learned from this study is that
adherence to a standardized guideline can result in good
patient outcome. Phased treatment is proposed, with the
initial emphasis on the treatment of septic foci, aiming to
improve the patient’s condition. Surgical repair is per-
formed when the patient is stable [34, 35]. After a recovery
period of at least 6 weeks, a one-stage treatment can be
performed successfully in most cases. Spontaneous closure
in the present series did not depend on output or anatomy,
whereas abdominal wall defect was a negative predictor.
Treatment of sepsis plays a key role and ongoing sepsis is
still the most important cause of death.
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